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PURPOSE:
The pathophysiology underlying the irreversibility of muscle atrophy and inability to regenerate following prolonged denervation is incompletely understood. Satellite cells (SCs) are the primary resident stem cells in muscle responsible for repair after injury, and are defined by expression of the transcription factor paired box protein 7 (Pax7). Previous studies reported SC depletion after longterm denervation, possibly explaining the irreversibility of denervation atrophy, but did not quantify Pax7 + cells nor perform functional studies. It is therefore unknown to what extent SC depletion occurs or limits recovery after delayed reinnervation. This study attempts to elucidate the effect of motor denervation on SC behavior and regenerative capacity.
METHODS:
The sciatic nerve of C57Bl6 mice was transected. Three, six, and 12 months following denervation, 100ug EdU was injected intraperitoneally for three consecutive days. Mice were sacrificed on day four and the tibialis anterior muscles (TAs) were processed for immunohistochemical analysis. Flow cytometry was used to select for SCs from lower leg muscles. Mitotracker staining was performed to assess mitochondrial activity in SC. SCs from three month-denervated legs or minced muscle grafts from six and twelve month-denervated TAs were transplanted into the pre-irradiated left TAs of immune-deficient/dystrophin-deficient (NSG-mdx) mice. SCs were isolated from the atrophic denervated gluteus maximus muscle of human patients with complete spinal cord injuries via flow cytometry and transplanted into irradiated left TAs of NSG mice.
RESULTS:
TAs weighed 11.9 ± 0.6mg after 3-month denervation vs 56.6.5 ± 5.5mg (p<0.05). No significant differences between three, six, and twelve-month denervated TA weights were noted. Cross-sectional fluorescent immunohistochemical staining demonstrated a significant increase in the total number of Pax7 + cells per muscle fiber in denervated TAs three and six months following denervation compared to nondenervated TAs (p<0.05). Twelve months following denervation, the number of Pax7 + cells in denervated TAs remains unchanged relative to non-denervated TAs. EdU uptake by SCs is significantly increased three months following denervation. SCs isolated from denervated legs were larger and had higher mitotracker uptake by flow cytometry compared to uninjured legs. After transplantation into the irradiated left TA of NSG-mdx mice, SCs from 3 month-denervated leg muscles were able to engraft and produce new muscle fiber. Minced muscle grafts from six and 12 month-denervated TAs also regenerated new muscle fibers after transplantation into NSG-mdx mice. SCs isolated from denervated human gluteus maximus and transplanted into NSG mice engrafted and made human dystrophin-producing muscle fibers. Following denervation, TGFbeta expression is increased in muscle, and downstream TGFbeta signaling is significantly increased in SCs as measured by Pax7-Smad2/3 co-staining.
CONCLUSION:
Contrary to previous reports, SC depletion does not occur following prolonged periods of denervation in either rodents or humans. The SC phenotype is altered from quiescence towards activation as demonstrated by their increase in number, size, EdU uptake, and mitochondrial activity postdenervation. SCs also retain robust intrinsic regenerative capacity when transplanted into a different host. The irreversibility of denervation atrophy cannot be explained by SC depletion or dysfunction. TGFbeta expression increases in muscle following denervation and may affect SC regenerative capacity.
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The Use of Paravertebral Nerve Blocks in Immediate Breast Reconstruction following Mastectomy: A Canadian Hospital-Perspective Cost Effectiveness Analysis

METHODS:
We retrospectively studied all patients who underwent immediate alloplastic breast reconstruction from 2010-2016. Data included the use of PVB, postoperative serial pain intensity scores, postoperative narcotic usage and length-of-stay in PACU. A cost-effectiveness analysis based on a net-benefit regression model was used to assess whether, from a hospitals perspective, the benefit gained from performing a PVB outweighed its additional costs compared to standard analgesia alone. The health outcome of interest was the average self-reported post-operative pain score. We also performed a sub-group analysis wherein we calculated the cost-effectiveness of specific patient cohorts according to laterality and type of mastectomy, extent of lymph node dissection and weather it was an expander or implant based.
RESULTS:
A total of 298 patients undergoing immediate breast reconstruction following mastectomy met inclusion criteria. Of these, 112(38%) patients underwent standard analgesic protocols and 186(62%) underwent PVB, in addition to standard analgesic protocols. Patients who received a PVB had significant reductions in average pain scores (2.8 vs 3.3, p=0.002), total opiate usage (52units vs 63units) (p=0.038) and length of stay in PACU (92min vs 142min) (p=0.0228). The cost-effectiveness base case results show that, for the average breast reconstruction patient, a PVB is associated with a net positive benefit to the hospital if the hospital values a unit reduction in a patient's pain score at about $2,000 or more. Sub-group analyses demonstrate that cost-effectiveness of PVB's vary significantly depending on the extent of the procedure. More specifically, a u-shaped relationship exists between the Incremental Cost Effectiveness Ratio (ICER) of the PVB and the invasiveness in subtype of immediate breast reconstruction.
CONCLUSIONS:
The present study demonstrates that PVB's are safe and effective at reducing narcotic usage, subjective pain and length of stay in the recovery room. Despite these promising results, a hospital perspective economic analysis is essential to ensure that such an intervention is cost-effective, particularly in the context of the Canadian public healthcare system. We illustrate here that a U-shaped relationship exists between ICER's and the extent of the immediate breast reconstruction, thereby demonstrating that such an intervention may only be cost effective in certain patient populations. To the best of our knowledge this is the first study to critically evaluate the cost-effectiveness of PVB's for immediate breast reconstruction in Canada and will hopefully inform future prospective randomized trials on PVB's in breast reconstruction. 
PURPOSE:
We examined whether tibial neurolysis performed as a surgical intervention for patients with diabetic neuropathy and superimposed tibial nerve compression in the prevention of the diabetic foot is cost saving and cost effective when compared to the current prevention program as per the Centers for Medicare and Medicaid Services (CMS).
